Rapid Response Revival

FUNDED July 2022 Anniversary Edition

Techboard's anniversary roundup catalogues a month of Australian startup funding: megadeals, three acquisitions, large debt deals, grants, accelerator intakes, and fund news including Archangel Ventures' committed capital.

Also Startup Daily·SmartCompany·SmartCompany·SmartCompany·Forbes Australia·Business News Australia

Extension and upsize of Series E Capital Raise

Rapid Response Revival reports strong demand for its Series E, upsizing the offer's maximum, confirming $4.2 million received so far, and extending the close toward first New Zealand sales.

Also Wholesale Investor

Rapid Response Revival launches Series E Capital Raise to raise $5m and executes agreement with a global electronics manufacturer for production of the CellAED® in Taiwan

Rapid Response Revival has opened a Series E offer of up to $5 million for working capital and trials, and finalised an agreement with an unnamed global OEM to manufacture the CellAED defibrillator in Taiwan from July.

Rapid Response Revival makes significant Board appointment and signs a mandate with a US Investment Bank as Lead Manager for the planned IPO in October

Defibrillator maker Rapid Response Revival appointed Cochlear executive Greg Bodkin as a non-executive director and signed a mandate with an unnamed US investment bank ahead of a planned October IPO.